Khavinson short peptide
Normoftal
Normoftal is one of the short peptides from Vladimir Khavinson's bioregulator programme in St Petersburg. The developer's 2014 review lists it as KE, the dipeptide lysine-glutamic acid, with a mass of 275 Da: the same sequence as Vilon. The developers assign it to the retina, but no peer-reviewed study names Normoftal, and work on the KE dipeptide in eye cells is limited to cell culture. This profile sets out what is published, what is a vendor claim, and what is not known.
- Also known as
- Normophthal, Lys-Glu (KE) as published, H-Lys-Glu-OH
- Published sequence
- Lys-Glu (KE), a dipeptide, per the developer's 2014 review
- Molecular mass
- 275.3 Da; C11H21N3O5
- Class
- Khavinson short peptide (bioregulator)
- CAS, UNII and PubChem (Lys-Glu)
- 45234-02-4, H34V7IM5ML, CID 7010502
- Same published sequence as
- Vilon
- Peptx availability
- 10mg research vial coming soon
Mechanism
Khavinson's programme began with peptide extracts of animal organs, such as Thymalin from the thymus and Retinalamin from the retina, and later made short synthetic peptides of two to four amino acids. The group calls these cytogens and assigns each to an organ. A 2019 review from the group says KE and the tetrapeptide AEDG (Epitalon) were designed from the amino acid make-up of Retinalamin.
The proposed mechanism, from the same group, is that peptides this small enter the cell and its nucleus and bind particular DNA sequences in gene promoter regions, changing which genes are read. Most support for this comes from computer modelling and test-tube binding studies; it has not been shown directly in living tissue. Our Vilon article covers the evidence on KE and DNA in detail.
For the retina, the group reported that KE and AEDG added to cultures of embryonic retinal cells increased markers of differentiation in retinal neurons and in the pigment epithelium, the layer that supports the light-sensing cells. A 2019 review adds that KE had the stronger effect on transthyretin, a pigment epithelium marker, while AEDG had more effect on neuronal markers.
What the evidence shows
- Research compound. Normoftal is not authorised as a medicine in the UK, EU or US. In Russia it is sold as a dietary supplement (BAA), with the label listing a peptide complex of lysine and glutamic acid.
- No peer-reviewed paper on PubMed names Normoftal, and ClinicalTrials.gov lists no trial of it as of 20 November 2026.
- Its published sequence, Lys-Glu (KE), is the dipeptide also sold as Vilon. A laboratory test of the powder can confirm the molecule, KE, but not which of the two names it was sold under.
- KE on eye cells: cell culture only. The embryonic retinal cell studies come from the institute that developed the peptide and have not been repeated by an independent group.
- The rat and human retina studies from the same institute used other preparations: Epitalon (AEDG), the retinal extract Retinalamin and the pineal extract Epithalamin. None of them tested KE or Normoftal.
- Other KE work, under the name Vilon, covers thymus and immune cell cultures, stem cell gene expression and one lifespan study in mice. Almost all of it comes from the developing group or its co-authors.
- Vendor claim, not evidence: listings that present Normoftal as a retina or eye bioregulator repeat the developer's stated purpose for it. That purpose has not been tested in a published trial.
Published statements, quoted
Reproduced verbatim from the sources named. Peptx makes no claim of its own on these points.
“We studied Molecular mechanisms of the retinoprotective effect of short peptides AEDG and KE.”
Coming soon
Normoftal 10mg research vial coming soon
Join the waitlist and we will email you when it lands.
Frequently asked questions
- What is Normoftal?
- Normoftal is a short peptide from Vladimir Khavinson's bioregulator programme. The developer's 2014 review lists it as KE, the dipeptide lysine-glutamic acid (Lys-Glu), with a mass of 275 Da, and assigns it to the retina. It is a research compound.
- Is Normoftal the same as Vilon?
- By published sequence, yes: both are listed as Lys-Glu (KE). The developers present Vilon for the thymus and immune system and Normoftal for the retina. A lab test can confirm the KE molecule but cannot tell which name it was sold under.
- Has Normoftal been tested in people?
- Not in any published or registered trial. As of November 2026 PubMed has no paper naming Normoftal and ClinicalTrials.gov lists no trial. Studies of KE on eye cells are limited to cell culture.
- How is Normoftal different from Visoluten and Retinalamin?
- Normoftal has a published sequence, Lys-Glu. Visoluten has no published sequence; its labels describe a peptide complex from eye tissue. Retinalamin is a polypeptide extract of animal retinas used clinically in Russia, not a single defined peptide.
- Does Peptx stock Normoftal?
- Not yet. A Normoftal 10mg research vial is coming soon. Join the waitlist on this page and we will email you when it lands.
Citations
- Khavinson VKh. (2014). Peptides, genome, aging. Advances in Gerontology 4:337-345, Table 1 lists Normoftal (KE), 275 Da. DOI 10.1134/S2079057014040134.
- Khavinson VKh, et al. (2013). Peptidegic regulation of differentiation of embryonic retinal cells. Bulletin of Experimental Biology and Medicine. PubMed 23667897.
- Khavinson V, et al. (2019). Molecular-Physiological Aspects of Regulatory Effect of Peptide Retinoprotectors. Stem Cell Reviews and Reports. PubMed 30859383.
- Khavinson VKh, et al. (2013). Short cell-penetrating peptides: a model of interactions with gene promoter sites. Bulletin of Experimental Biology and Medicine. PubMed 23484211.
- Khavinson VKh, et al. (2003). Retinoprotective effect of Epithalon in Campbell rats of various ages. Bulletin of Experimental Biology and Medicine. PubMed 12910293.
- Khavinson VK, et al. (2000). Effect of vilon on biological age and lifespan in mice. Bulletin of Experimental Biology and Medicine. PubMed 11140587.
- PubChem compound record CID 7010502: Lys-Glu (lysylglutamic acid), synonyms include Vilon and Normophthal.
- RLS encyclopedia (Russia): Normoftal, listed as a dietary supplement (BAA), peptide complex AKS-G (lysine, glutamic acid).
- ClinicalTrials.gov registry search: Normoftal.